More eye drops recalled for lacking sterility
Two additional brands of eye drops have initiated recalls, but are not tied to a spate of previous recalls over potentially contaminated eye drops.
LEARN MORE68 injuries, 4 eyeball removals tied to recalled EzriCare eye drops
The CDC said anyone using EzriCare Artificial Tears needs to immediately stop as it investigates the incidents.
CDC
March 17, 2023
The Centers for Disease Control and Prevention is now investigating 68 cases of eye injuries tied to recalled eye drops.
The CDC encouraged the public to immediately stop using EzriCare Artificial Tears in February due to potential bacterial contamination. Of the 68 incidents potentially tied to the products, one was fatal.
The CDC confirmed that four of the incidents resulted in the surgical removal of the eyeball, according to updated figures released this week. The CDC added eight infections caused permanent vision loss.
Global Pharma Healthcare Private Limited makes the products and initiated a recall of the products.
Officials said isolates from those infected detected VIM‐GES‐CRPA, which are highly antimicrobial drug-resistant pathogens that are uncommon in the United States, according to the National Institutes of Health.
Officials said the presence of VIM-GES-CRPA in opened EzriCare bottles from multiple lots was detected. These bottles came from customers with and without eye infections, the CDC said.
“CDC recommends that clinicians and patients immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete,” the CDC said last month.
California to manufacture its own insulin, cap cost at $30
California has partnered with a manufacturer to produce insulin that is expected to save residents hundreds of dollars every month.
Pfizer recalls migraine pill packs due to child safety risk
Pfizer is recalling Nurtec ODT 75 milligram tablets because the products are not in child-resistant packaging.
Sanofi is the latest insulin maker to announce price cap
Sanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress to enact limits.
Top Stories
10:24
Why does today's audience say certain fictional characters are gay?
In this segment of "Pop Quiz," Scripps News explores how historians and viewers are speculating about queer subtext in new and old media.
2:50
Los Angeles school support staff at an impasse in higher pay talks
Cafeteria workers, bus drivers and other school support staff employees say the district isn't meeting their requests.
3:01
This basketball magazine is mixing art with 'outlandish' sport stories
Flagrant Magazine is carving out its own space in the sports media industry by mixing abstract basketball art with culture stories from off the court.
